Stock listing
Bioceltix Sa
Selected listing: A3C7NH · LS · EUR · DE
Bioceltix Sa (Lang & Schwarz: A3C7NH), Health Technology. Latest release Jun 10, 2026: Bioceltix Receives Permit For Biological Veterinary Drugs Facility.
- Ticker
- Lang & Schwarz: A3C7NH
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Bioceltix Sa
The company focuses on biotechnology and is involved in developing innovative solutions in its field. Bioceltix aims to advance healthcare through its research and product offerings.
Latest news from Bioceltix Sa
Bioceltix Receives Permit For Biological Veterinary Drugs Facility
June 10, 2026
BCX: Strong cash position, regulatory progress, and major investments mark Q1 2026 pre-commercial phase
May 29, 2026
BCX: Advanced cell therapy pipeline, secured funding, and strengthened readiness for commercialization
April 28, 2026
Bioceltix Signs Advisory Agreement For FDA Regulatory Support
April 14, 2026
BCX: Pioneering stem cell therapies for pets, with proven efficacy and major market expansion plans
March 31, 2026